VHA says it will NOT offer controversial new Alzheimer's drug Aduhlem to veterans

The Veterans Health Administration will not offer Aduhelm, a controversial drug developed by Biogen that received accelerated FDA approval in June. Many have doubted the drug's effectiveness.

from U.S. Home | Mail Online https://ift.tt/3yHzCjL
via Top U.S. Stories